MDR – MedAdvisor Limited | Aussie Stock Forums

Demand for vaccination delivery via retail pharmacies is expected to grow – this will accelerate opportunities to market MedAdvisor/ Adheris Health services, especially with multiple vaccine manufacturers. Vaccine awareness campaigns and dose series completion programs benefit patients, pharmacies and manufacturers.

Adheris Health can execute these awareness and series completion programs to patients. Adheris has run numerous vaccine programs successfully in the past – the company’s vaccine product was the largest revenue product in CY20, highlighting the near-term opportunity for MedAdvisor in this market. …

Be the first to comment

Leave a Reply

Your email address will not be published.


*